Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
3-O-Methyldopa, L-Dopa, and Trihexyphenidyl in the Treatment of Parkinson’s Disease | Synapse
March 3, 2026
3-O-Methyldopa, L-Dopa, and Trihexyphenidyl in the Treatment of Parkinson’s Disease
MM
Manfred D. Muenter
Mayo Clinic in Arizona
RD
Robert P. Dinapoli
Mayo Clinic
NS
Nansie S. Sharpless
Ver todo
Puntos clave
L-Dopa significantly improves motor function in Parkinson's disease, often serving as the first-line treatment.
Trihexyphenidyl is effective for managing tremors, although it may cause side effects such as dry mouth.
3-O-methyldopa shows potential as an alternative treatment but requires further investigation for wider application.
Patient responses vary, indicating the need for personalized treatment strategies in managing Parkinson’s symptoms.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Muenter et al. (Thu,) studied this question.
synapsesocial.com/papers/69a761c6c6e9836116a2fd74
https://doi.org/https://doi.org/10.1016/s0025-6196(26)07959-0